Dr. Kai Yao 尧凯
Chief Physician, Associate Professor
Department of Urology, Sun Yat-sen University Cancer Center, Guangzhou
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of urologic and male reproductive system tumors, including open, laparoscopic, and robot-assisted surgery.
Dr. Yao holds an MD and serves as Chief of the Department of Urology at Sun Yat-sen University Cancer Center. With extensive clinical experience, Dr. Yao has performed over 8,000 urologic tumor surgeries. Research on penile cancer contributed to EAU and NCCN guidelines, and informed the 2017 AJCC-TNM staging revisions for penile cancer.
Professional roles
- Reviewer, Urologic Oncology: Seminars and Original Investigations
- Reviewer, World Journal of Surgical Oncology
Name order: in Chinese the family name comes first (Yao Kai). Papers usually list the name as Kai Yao or Yao K.
Selected publications
111 papers on PubMed matched by name and affiliation; 21 as first or senior author since 2016. Most recent first- or senior-author papers:
- J Immunother Cancer, 2026 (senior author): Intratumoral Klebsiella pneumoniae drives metabolic-immune remodeling and immunotherapy resistance in bladder cancer. PubMed 42946394
- MedComm (2020), 2026 (senior author): The Expression Patterns of Antibody-Drug Conjugate-Related Markers in Urothelial Carcinoma With Histological Variants. PubMed 42460129
- Cancer, 2026 (senior author): Diagnostic performance analysis of two-gene methylation in urothelial carcinoma based on small-volume urine sample. PubMed 41874814
- Oncol Res, 2025 (senior author): TROP-2 Promotes Cell Proliferation via the AKT-Mediated PKCα Pathway and Is a Novel Target for Antibody-Drug Conjugates in Penile Carcinoma. PubMed 41425706
- Cancer Med, 2025 (senior author): An Evaluation of HER2 Expression Heterogeneity in Primary Tumors and Metastatic Lymph Nodes of Patients With Advanced Extramammary Paget's Disease: Prognostic and Therapeutic Implications. PubMed 41054956
- Discov Oncol, 2025 (senior author): HER2 prognostic values in non-muscle-invasive bladder cancer: a step towards personalized treatment for BCG instillation. PubMed 40410618
- Eur Urol Oncol, 2024 (senior author): Prognostic Significance of HER2 Expression in Patients with Bacillus Calmette-Guérin-exposed Non-muscle-invasive Bladder Cancer. PubMed 37884420
- Int J Surg, 2024 (senior author): Regional lymph node mapping in patients with penile cancer undergoing radical inguinal lymph node dissection - a retrospective cohort study. PubMed 38329065
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion